Lillian L. Siu
Runs one of the world's largest phase 1 programmes and led trials that shaped head and neck cancer immunotherapy.
Medical oncologist who directs Princess Margaret's phase 1 unit, led KEYNOTE and immunotherapy studies in head and neck cancer, and pioneers ctDNA-guided early trials; AACR president 2025-26.
Pages like this
not linked directly; found by shared links- PersonNatasha B. Leighl
Shares Princess Margaret Cancer Centre, Liquid biopsy (ctDNA).
- PersonTrevor J. Pugh
Shares Princess Margaret Cancer Centre, Liquid biopsy (ctDNA).
- PersonTak W. Mak
Shares Princess Margaret Cancer Centre, Immune checkpoint inhibitors.
- PersonCharu Aggarwal
Shares Liquid biopsy (ctDNA), Head and neck squamous cell carcinoma.
- PersonHye Ryun Kim
Shares Head and neck squamous cell carcinoma, Immune checkpoint inhibitors.
- IdeaBlood EBV DNA screening for nasopharyngeal cancer across southern China and Southeast Asia
Shares Liquid biopsy (ctDNA), Head and neck squamous cell carcinoma.
- TrialJAVELIN Head and Neck 100
Shares Head and neck squamous cell carcinoma, Immune checkpoint inhibitors.
- InstitutionQueen Mary Hospital / University of Hong Kong
Shares Liquid biopsy (ctDNA), Head and neck squamous cell carcinoma.